Welcome to Multibagg AI
Log in to access personalized features
Discovery themes featuring this stock
Astonea Labs Ltd is focused on manufacturing and marketing pharmaceutical and cosmetic products, including antibiotics and multivitamins, used for skin, hair, and tooth care.
The company also operates as a contract manufacturer for both domestic and international firms, highlighting its expansive operational reach.
In recent strategic moves, Astonea Labs announced plans for a public issue of 27,90,000 Equity Shares, signaling potential growth and expansion.
Astonea Labs markets its own products in India under the brands 'Glow Up' and 'Regero', showcasing its diversified product portfolio.
The company has steadily expanded its production capabilities since 2019, indicating robust growth in its manufacturing operations.
Pharmaceuticals & Biotechnology
Pharmaceuticals
276 Cr
Low Risk
61.1
35.1
0.3
4.8
301.30
118.00
Sales CAGR
Profit CAGR
ROE
ROCE
Bearish
2
Neutral
6
Bullish
6
Bearish
4
Neutral
6
Bullish
36
Bearish
2
Neutral
0
Bullish
30
Get instant AI-powered insights about company performance, financials, and strategy. Ask questions about trends, competition, and developments while receiving responses backed by official documents and market data, with clear attribution to source documents.
Dashboard
Portfolio
Ask Iris
Discovery
Timeline
Multibagg AI is an AI powered stock research and analysis platform. We provide data, information, content, and analytics for publicly traded Indian companies listed on NSE and BSE. AI can make mistakes, check important information.
Prices might be delayed by a few minutes.
Join our Exclusive Community
Join our Exclusive Community
Made with 💙 in India. © Finsky Technologies Pvt Ltd. 2026
Discover detailed, AI-driven financial summaries that break down key metrics, trends, and insights—empowering you to make smarter investment decisions.
Astonea Labs Ltd (ASTONEALAB) is currently trading at N/A per share. Stock prices fluctuate during market hours on NSE and BSE based on demand, company updates, and overall market conditions. Refer to the live price chart above for the most recent price movement.
Astonea Labs Ltd is focused on manufacturing and marketing pharmaceutical and cosmetic products, including antibiotics and multivitamins, used for skin, hair, and tooth care. The company also operates as a contract manufacturer for both domestic and international firms, highlighting its expansive operational reach. In recent strategic moves, Astonea Labs announced plans for a public issue of 27,90,000 Equity Shares, signaling potential growth and expansion. Astonea Labs markets its own products in India under the brands 'Glow Up' and 'Regero', showcasing its diversified product portfolio. The company has steadily expanded its production capabilities since 2019, indicating robust growth in its manufacturing operations.
Over the past 52 weeks, Astonea Labs Ltd has traded between a low of ₹118.00 and a high of ₹301.30. The 52-week high and low indicate the stock’s price range over the last year and help investors understand its volatility and recent trading levels.
Astonea Labs Ltd has a market capitalization of approximately 276.02. Market capitalization represents the total value of a company’s outstanding shares and helps investors understand its size, stability, and relative risk compared to other listed companies.
Astonea Labs Ltd’s investment profile depends on its business fundamentals, valuation, and long-term outlook. The stock currently trades at a PE ratio of 61.07 and operates in the its sector sector. Investors typically assess financial performance, growth prospects, and individual risk tolerance before making investment decisions.
Based on its market capitalization of 276.02 Cr, Astonea Labs Ltd is classified as a Small Cap stock. Large-cap stocks are generally more stable, while mid-cap and small-cap stocks tend to offer higher growth potential along with higher price volatility.
Astonea Labs Ltd operates in the its sector sector. Sector classification matters because companies in the same sector are often affected by similar economic conditions, regulatory changes, and competitive dynamics, which can influence overall stock performance.
The Price-to-Earnings (PE) ratio of Astonea Labs Ltd is 61.07. The PE ratio compares a company’s share price to its earnings and is commonly used to assess valuation. Comparing the PE ratio with sector peers and historical levels provides better context.
| Symbol | Watchlist | Price | Market Cap | P/E | P/B | Div Yield (%) | ROE (%) | ROCE (%) | ROA (%) |
45.75 | 279 Cr | -260.94 | 2.94 | 0.00 | -1.13 | 4.36 | -0.96 | ||
262.60 | 276 Cr | 61.07 | 4.83 | 0.00 | 7.90 | 8.87 | 3.09 | ||
91.87 | 260 Cr | 57.63 | 1.73 | 0.00 | 2.64 | 5.20 | 1.52 | ||
10.72 | 260 Cr | 14.00 | 1.17 | 0.00 | 8.29 | 9.09 | 6.02 | ||
450.00 | 258 Cr | 23.89 | 3.41 | 1.11 | 14.04 | 19.30 | 10.92 | ||
274.00 | 258 Cr | 46.47 | 3.42 | 0.00 | 7.35 | 11.62 | 2.32 | ||
71.00 | 250 Cr | -24.94 | 2.70 | 0.00 | -10.86 | -6.04 | -5.98 | ||
| Median: 7 Co. | — | 91.87 | 260 Cr | 23.89 | 2.94 | 0.00 | 7.35 | 8.87 | 2.32 |
Revised financial results
Astonea Labs submitted revised audited standalone financial results and supporting documents to BSE responding to its queries, confirming Board approval and that Director Pardeep Dalal was authorised to sign the results; no other changes to prior filing.
Revised Financial Results
Company submitted revised audited standalone financial results and attached a board resolution authorizing Director Mr. Pardeep Dalal to sign the FY2025-26 results in response to BSE observations; auditor's report enclosed.
